By G HossainPosted on February 24, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. Generate’s IPO Could Reach $425M, Largest Raise Yet Post navigation AbbVie Backs Obesity Push With $380M API Production Expansion Project in IllinoisNovo Returns to Pre-Wegovy Valuation as Lilly Makes History as First Ever $1T Pharma